Funded Tech Companies

Graphite Bio

Graphite Bio, based in San Francisco, received equity investments through Fidelity Management & Research Company, OrbiMed and Deerfield Capital.

Company Overview

Company Name
Graphite Bio
Company Status
Publicly-held
Funding Rounds

Contact Information

Mailing Address
279 E. Grand Ave. 430
San Francisco, CA 94025
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Graphite Bio is a next-generation gene editing company focused on targeted DNA integration to precisely insert genetic payloads to treat a broad range of severe diseases. The company was co-founded by academic pioneers in the fields of gene editing and gene therapy, and is backed by Versant Ventures and Samsara BioCapital.
Profile
Graphite Bio LinkedIn Company Profile
Social Media
Graphite Bio Company Twitter Account
Company News
Graphite Bio News
Facebook
Graphite Bio on Facebook
YouTube
Graphite Bio on YouTube
Last Transaction
6/25/2021

Financing History

Date
Type
Amount
IPO
$212,500,000
Venture Equity
$150,000,000
Venture Equity
$45,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Josh Lehrer
  Josh Lehrer LinkedIn Profile  Josh Lehrer Twitter Account  Josh Lehrer News  Josh Lehrer on Facebook
Chief Operating Officer
Katherine Stultz
  Katherine Stultz LinkedIn Profile  Katherine Stultz Twitter Account  Katherine Stultz News  Katherine Stultz on Facebook
VP - Bus. Development
Philip Gutry
  Philip Gutry LinkedIn Profile  Philip Gutry Twitter Account  Philip Gutry News  Philip Gutry on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Graphite | Graphite by Screenplay Studios

 

Share this article

 


About Our VC Transaction Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary